Lynch Thomas J. Jr. - Net Worth and Insider Trading
Lynch Thomas J. Jr. Net Worth
The estimated net worth of Lynch Thomas J. Jr. is at least $380,124 dollars as of 2024-06-01. Lynch Thomas J. Jr. is the EVP & Chief Scientific Officer of Bristol-Myers Squibb Co and owns about 9,251 shares of Bristol-Myers Squibb Co (BMY) stock worth over $380,124. Details can be seen in Lynch Thomas J. Jr.'s Latest Holdings Summary section.
Disclaimer: The insider information is derived from SEC filings. The estimated net worth is based on the assumption that Lynch Thomas J. Jr. has not made any transactions after 2017-12-12 and currently still holds the listed stock(s).
Transaction Summary of Lynch Thomas J. Jr.
Lynch Thomas J. Jr. Insider Ownership Reports
Based on ownership reports from SEC filings, as the reporting owner, Lynch Thomas J. Jr. owns 3 companies in total, including Bristol-Myers Squibb Co (BMY) , Infinity Pharmaceuticals Inc (INFIQ) , and Foghorn Therapeutics Inc (FHTX) .
Click here to see the complete history of Lynch Thomas J. Jr.’s form 4 insider trades.
Insider Ownership Summary of Lynch Thomas J. Jr.
| Ticker | Comapny | Transaction Date | Type of Owner |
|---|---|---|---|
| BMY | Bristol-Myers Squibb Co | 2017-12-12 | director |
| INFIQ | Infinity Pharmaceuticals Inc | 2009-10-06 | director |
| FHTX | Foghorn Therapeutics Inc | 2022-10-27 | director |
Lynch Thomas J. Jr. Latest Holdings Summary
Lynch Thomas J. Jr. currently owns a total of 1 stock. Lynch Thomas J. Jr. owns 9,251 shares of Bristol-Myers Squibb Co (BMY) as of December 12, 2017, with a value of $380,124.
Latest Holdings of Lynch Thomas J. Jr.
| Ticker | Comapny | Latest Transaction Date | Shares Owned | Current Price ($) | Current Value ($) |
|---|---|---|---|---|---|
| BMY | Bristol-Myers Squibb Co | 2017-12-12 | 9,251 | 41.09 | 380,124 |
Holding Weightings of Lynch Thomas J. Jr.
Lynch Thomas J. Jr. Form 4 Trading Tracker
According to the SEC Form 4 filings, Lynch Thomas J. Jr. has made a total of 0 transactions in Bristol-Myers Squibb Co (BMY) over the past 5 years. The most-recent trade in Bristol-Myers Squibb Co is the sale of 5,300 shares on December 12, 2017, which brought Lynch Thomas J. Jr. around $335,172.
Insider Trading History of Lynch Thomas J. Jr.
- 1
Lynch Thomas J. Jr. Trading Performance
Lynch Thomas J. Jr. Ownership Network
Lynch Thomas J. Jr. Owned Company Details
What does Bristol-Myers Squibb Co do?
Who are the key executives at Bristol-Myers Squibb Co?
Lynch Thomas J. Jr. is the director of Bristol-Myers Squibb Co. Other key executives at Bristol-Myers Squibb Co include EVP & Chief Commercial Officer Christopher S. Boerner , EVP & Corporate Affairs Cari Gallman , and SVP & Human Resources Ann Powell Judge .
Bristol-Myers Squibb Co (BMY) Insider Trades Summary
Over the past 18 months, Lynch Thomas J. Jr. made no insider transaction in Bristol-Myers Squibb Co (BMY). Other recent insider transactions involving Bristol-Myers Squibb Co (BMY) include a net sale of 29,169 shares made by Ann Powell Judge , a net purchase of 5,071 shares made by Christopher S. Boerner , and a net sale of 240,000 shares made by Giovanni Caforio .
In summary, during the past 3 months, insiders sold 0 shares of Bristol-Myers Squibb Co (BMY) in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 320,286 shares of Bristol-Myers Squibb Co (BMY) were sold and 13,571 shares were bought by its insiders, resulting in a net sale of 306,715 shares.
Bristol-Myers Squibb Co (BMY)'s detailed insider trading history can be found in Insider Trading Tracker table.
Bristol-Myers Squibb Co Insider Transactions
Lynch Thomas J. Jr. Mailing Address
Above is the net worth, insider trading, and ownership report for Lynch Thomas J. Jr.. You might contact Lynch Thomas J. Jr. via mailing address: 800 Howard Avenue, Yale Physicians Building, 2nd Floor, New Haven Ct 06519.
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
